Experimental Injection Promises Self‑Destructing Fat Cells to Combat Obesity

Scientists have created an experimental injection that triggers the self‑destruction of fat cells, leading to a marked reduction in dangerous abdominal fat. Early studies indicate the treatment could also curb the weight regain that frequently follows the discontinuation of popular weight‑loss drugs such as Ozempic and Wegovy. By targeting visceral fat—known to increase the risk of heart disease, diabetes, and other metabolic disorders—the new therapy offers a potential alternative to current pharmacological and lifestyle interventions. While still in the research phase, the findings suggest a novel mechanism that could enhance long‑term weight management and reduce obesity‑related health complications.